FDA Inspection 1163644 — Peter Charles Klatsky, M.D., Inc.
The FDA completed an inspection of Peter Charles Klatsky, M.D., Inc. on Feb 17, 2022 in San Francisco, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 17, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- San Francisco, CA (United States)